Literature DB >> 14764740

A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8.

Jacqueline A Taylor1, Evis Havari, Marcia F McInerney, Roderick Bronson, Kai W Wucherpfennig, Myra A Lipes.   

Abstract

Genome-wide analyses have shown that the MHC class II region is the principal locus that confers susceptibility to a number of human autoimmune diseases. Due to the high degree of linkage disequilibrium across the MHC, it has been difficult to dissect the contribution of individual genes to disease susceptibility. As a result, intensive efforts have been made to generate mice transgenic for human class II molecules as models of autoimmune disease. However, in every case, additional manipulations-such as immunization with Ag in adjuvant, expression of immunostimulants on target tissues, or coexpression of TCR transgenes-have been required to induce disease. In this study, we show that expression of the human HLA-DQ8 (DQA1*0301/DQB1*0302) molecule alone in three lines of transgenic nonobese diabetic murine class II-deficient (mII(-/-)) mice results in the spontaneous development of autoimmune myocarditis. The disease shares key features of human myocarditis and was characterized by lymphocytic infiltrates in the myocardium and cardiac myocyte destruction, circulating IgG autoantibodies against cardiac myosin heavy chain, and premature death due to heart failure. We demonstrate that myocarditis could be transferred into healthy HLA-DQ8(+)RAG-1(-/-)mII(-/-) nonobese diabetic recipients with lymphocytes, but not sera. It has been widely thought that autoimmune myocarditis is of infectious etiology, with the immune responses arising secondary to cardiac damage from pathogens. These studies provide direct experimental evidence that spontaneous autoimmune myocarditis can occur in the absence of infection and that expression of HLA-DQ8 confers susceptibility to this organ-specific autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764740     DOI: 10.4049/jimmunol.172.4.2651

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes.

Authors:  Raju V S R K Gottumukkala; HuiJuan Lv; Lizbeth Cornivelli; Amy J Wagers; Raymond Y Kwong; Roderick Bronson; Garrick C Stewart; P Christian Schulze; William Chutkow; Howard A Wolpert; Richard T Lee; Myra A Lipes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

Review 2.  Animal models of human type 1 diabetes.

Authors:  Matthias von Herrath; Gerald T Nepom
Journal:  Nat Immunol       Date:  2009-02       Impact factor: 25.606

Review 3.  Role of impaired central tolerance to α-myosin in inflammatory heart disease.

Authors:  HuiJuan Lv; Myra A Lipes
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

Review 4.  Thinking bedside at the bench: the NOD mouse model of T1DM.

Authors:  James C Reed; Kevan C Herold
Journal:  Nat Rev Endocrinol       Date:  2015-01-27       Impact factor: 43.330

5.  Myocarditis: a defect in central immune tolerance?

Authors:  Todd C Metzger; Mark S Anderson
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

6.  Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice.

Authors:  Veena Taneja; Marshall Behrens; Leslie T Cooper; Satsuki Yamada; Hirohito Kita; Margret M Redfield; Andre Terzic; Chella David
Journal:  J Mol Cell Cardiol       Date:  2007-03-27       Impact factor: 5.000

7.  Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis.

Authors:  Gabriel K Griffin; Andrew H Lichtman
Journal:  Circulation       Date:  2013-05-13       Impact factor: 29.690

8.  Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Authors:  Julie A Lucas; Julia Menke; Whitney A Rabacal; Frederick J Schoen; Arlene H Sharpe; Vicki R Kelley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 9.  Vascular dysfunction in idiopathic dilated cardiomyopathy.

Authors:  Santiago Roura; Antoni Bayes-Genis
Journal:  Nat Rev Cardiol       Date:  2009-07-28       Impact factor: 32.419

10.  FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

Authors:  Ferenc Boldizsar; Oktavia Tarjanyi; Katalin Olasz; Akos Hegyi; Katalin Mikecz; Tibor T Glant; Tibor A Rauch
Journal:  Cardiovasc Pathol       Date:  2016-05-17       Impact factor: 2.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.